Leading Transplantation Support and Research at NMDP and CIBMTR With Richa Thakur, MD, and Steven Devine, MD
Expert Perspectives · Keira Smith · 2024-07-31
Following this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, Richa Thakur, MD, a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health, sat down for a discussion with Steven Devine, MD, Chief Medical Officer of NMDP and Senior Scientific Director at the CIBMTR (Center for International Blood and Marrow Transplant Research). In this podcast, Dr. Thakur and Dr. Devine have an enlightening conversation about NMDP and its importance, including:
- An overview of the research that CIBMTR conducts in conjunction with NMDP
- How bone marrow donation and transplantation for blood cancers and autoimmune diseases have evolved in recent years
- Results from the ACCESS trial presented at ASCO
- Patient diversity in clinical trials and how representation matters to continue understanding these diseases
- Next steps for the ACCESS and OPTIMIZE studies
- And more!
About Dr. Thakur and Dr. Devine
Richa Thakur, MD, is both a Palliative Care Physician and Hematology/Oncology Fellow at Zucker School of Medicine at Hofstra/Northwell Health. She graduated from Washington University in St. Louis with a bachelor’s in chemistry, medical school at Texas A&M, residency in Internal Medicine, and a fellowship in Palliative Care at Zucker School of Medicine. Her research interests include improving quality of life in patients diagnosed with hematologic malignancies.
Steven Devine, MD, is the Chief Medical Officer of NMDP and Senior Scientific Director at the CIBMTR (Center for International Blood and Marrow Transplant Research). In addition, Dr. Devine is the Director of the Blood and Marrow Transplant Program at Ohio State University Hospital in Columbus. His research focuses on blood cancers and bone marrow transplantation.